Testing Integrative Smoking Cessation for HIV Patients

University of Miami95 enrolled

Overview

The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Smoking Smoking Cessation HIV Infections

Interventions

Nicotine Replacement TherapyDRUG

6 weeks of Nicotine replacement patches

Mindfulness Training Smoking Cessation InterventionBEHAVIORAL

Mindfulness Training Smoking Cessation Intervention administered online via Zoom. Each session lasts 60-90 minutes, twice weekly for 4 weeks for a total of 8 sessions.

Contingency Management Smoking Cessation InterventionBEHAVIORAL

Contingency Management Smoking Cessation Intervention includes one orientation session lasting about 60-90 minutes administered via Zoom. Participants will then be required to contact the research associate about their quitting progress three times a week for 4 weeks also by zoom.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with HIV (based on self-report). * Be 18 years and older * Have smoked ≥ 5 cigarettes/day in the past year * Be interested in making a quit attempt in the next 30 days * Own a smartphone (apple/android), and plan to keep it active for the next 6 months * Able to consent * Have no plans to move in the next 6 months * Are not pregnant or planning to be pregnant in the following 6 months * Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements Exclusion Criteria: * Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder) * Are currently being treated for a psychiatric condition. * Are currently being treated for smoking cessation, alcoholism, or illicit drug use * Are adults unable to consent * Are individuals who are not yet adults * Are pregnant women * Are prisoners

Locations (1)

University of Miami

Miami, Florida, United States

Outcomes

Primary Outcomes

Number of Participants Reporting 7-day Point-prevalence Abstinence

Defined as self-report of not smoking in the past 7-days, not even a puff and confirmed by expired carbon monoxide (CO) level cutoff of \< 8 ppm using a coVita iCO™ Smokerlyzer® and/or NicoTests saliva sample of ≤ 30 ng/mL.

Time frame: 4 weeks (end of treatment), and 3 months

Secondary Outcomes

Retention Rate

Treatment specific retention rates reported as the percentage of participants who completed their final 3-month assessment divided by the total of participants enrolled.

Time frame: 3 months

Treatment Specific Adherence Rates

Defined as number of phone-call check-ins attended by each participant (4 for mindfulness training, 12 for contingency management).

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.